Drug class in one race
Amyloid-beta (monoclonal antibody) drugs for Alzheimer's Disease
12 tracked Amyloid-beta (monoclonal antibody) drugs in the Alzheimer's Disease race. The class explanation lives on the Amyloid-beta (monoclonal antibody) page; the full indication pipeline across every mechanism is on the Alzheimer's Disease page.
2 approved / phase 42 Phase 33 Phase 21 Phase 1/24 Phase 1
Head-to-head evidence: ABBV-1758 vs ALIA-1758 · ABBV-1758 vs ALZ-101 · ABBV-1758 vs AV-1959R · ABBV-1758 vs CM383 · ABBV-1758 vs Donanemab · ABBV-1758 vs Lecanemab